Coronary vein graft disease: pathogenesis and prevention.
about
Novel no touch technique of saphenous vein harvesting: Is great graft patency rate provided?Clinical Outcomes of Revascularization Strategies for Patients With MVD/LMCA Disease: A Systematic Review and Network Meta-AnalysisAnti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.Collagen External Scaffolds Mitigate Intimal Hyperplasia and Improve Remodeling of Vein Grafts in a Rabbit Arteriovenous Graft Model.Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.Mild anastomotic stenosis in patient-specific CABG model may enhance graft patency: a new hypothesis.Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgerySimultaneous Increases in Proliferation and Apoptosis of Vascular Smooth Muscle Cells Accelerate Diabetic Mouse Venous Atherosclerosis.Association of Angiotensin-Converting Enzyme Genotype, Insertion/Deletion Polymorphism and Saphenous Vein Graft Atherosclerosis in Iranian Patients.Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice.Gene therapy for the prevention of vein graft diseaseEarly growth response protein 1 promotes restenosis by upregulating intercellular adhesion molecule-1 in vein graft.Inhibition of vein graft stenosis with a c-jun targeting DNAzyme in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE).Association between platelet to lymphocyte ratio and saphenous vein graft disease in patients with stable angina pectoris.Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia?Vein graft failure: from pathophysiology to clinical outcomes.Cardiovascular Risk Reduction is Important for Improving Patient and Graft Survival After Ligation and Bypass Surgery for Popliteal Artery Aneurysm.Full Mimicking of Coronary Hemodynamics for Ex-Vivo Stimulation of Human Saphenous Veins.Competitive flow arising from varying degrees of coronary artery stenosis affects the blood flow and the production of nitric oxide and endothelin in the internal mammary artery graft.Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA.Optimisation of a Novel Spiral-Inducing Bypass Graft Using Computational Fluid Dynamics."Topical" HDL for vein grafts: a new solution to an old problem?Is increased homocysteine level a false trail or an accomplice to saphenous venous graft degeneration?Preimplantation processing of ex vivo-derived vascular biomaterials: effects on peripheral cell adhesion.A compact and automated ex vivo vessel culture system for the pulsatile pressure conditioning of human saphenous veins.Platelet distribution width and saphenous vein disease in patients after CABG. Association with graft occlusion.Management and Prevention of Saphenous Vein Graft Failure: A Review.Relationship between neutrophil-to-lymphocyte ratio and saphenous vein graft disease in patients with coronary bypass.A comparison of postoperative morphometric and hemodynamic changes between saphenous vein and left internal mammary artery grafts.Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.The relationship between lymphocyte-to-monocyte ratio and saphenous vein graft patency in patients with coronary artery bypass graft.Plateletcrit. A platelet marker associated with saphenous vein graft disease.Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.Impact of glucose control on early vein graft failure after coronary artery bypass grafting: one-month angiographic results.Authors Reply.Effects of arterial blood on the venous blood vessel wall and differences in percentages of lymphocytes and neutrophils between arterial and venous blood.Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional studyShape optimization for viscous flows by reduced basis methods and free-form deformation
P2860
Q26743408-5D417487-DC39-40F5-89D3-3F4E2F8B8D1FQ26779886-4CCAFB7C-9C3A-488B-9028-474E8FFA8CA9Q33404709-A69EB720-6D4B-4A42-A5A7-62B0F41E963AQ33630978-63E96C52-26D2-4D5D-AF94-5AFB43EA15C6Q34389129-521A8C03-86CE-4A5D-B5E5-4D1583FF87EDQ34684861-E7E9E904-9862-44C7-A113-122493FE29BDQ34994408-321CD10E-25D0-4690-B6E7-0A9FF3426AAEQ35072359-99857AA8-8A20-45AF-8840-7466672CE842Q35815734-2D648544-3B3A-43FD-A817-098C6FE39922Q36402889-FCB0CB68-52EA-409E-9384-1C3C4A16FF8AQ36476340-DF8D37A4-289E-4F4B-A029-03B8E2BA5219Q36698258-EEAF7508-8B97-404B-8CC3-0B719D6FC932Q37412897-126332D3-1D64-427F-BCE7-47F68406C61DQ37633665-F6A6BD30-7BC4-4E36-A30F-008981ACC06BQ37680325-98EE0D1C-39BB-4CBF-89E1-3F67438C8FFBQ38220601-49D1F99C-0122-480C-A384-6F597B429707Q38837879-F23873DE-7807-4BDD-8244-E8AD80719289Q39219914-A2EF378C-E79A-430F-BD74-6CC9730CBC0BQ39279051-A9AF4D57-1B98-4132-98FF-A400E547E9C1Q39548585-51C72C41-D81C-42D5-8623-5277B88798FEQ41531960-B7C5490F-847F-483C-81A8-1767AFDB7FC8Q42053303-D6E33637-71D9-4689-8A66-A5226E6E8991Q42067435-181E874B-14DC-460F-870E-622B745D50B8Q42320036-29CC18AB-D584-4987-84E0-B564BBA61086Q42349280-5CDA7803-B275-4A30-81D4-283B4B63AF06Q43678855-B2C10593-1B26-4ADC-9F87-2D87251E50EAQ44901799-AF93E05B-0420-4C17-A7EE-D47E80ABDFE9Q46000351-362EF679-9775-4562-84F3-156FC3E6DB1AQ46833779-3746B2E8-5C48-4851-9681-25FE877F78C1Q47103886-77D73898-E3E9-4879-9460-F45A4B272EA1Q47994855-929CB002-AFA9-48E4-B342-65682370FD10Q49613427-030B4003-506A-4D0F-8BF3-EBC9208E6EE6Q50492517-09828F5A-51F4-421D-AE3E-E33281950264Q51194759-1ACCD530-4DED-45D1-A15E-F5BADB8A556DQ51740347-8FE3F748-8D26-480C-A0B7-322486288225Q53900581-5AAE9C8D-8F33-4C56-9076-8AEA34450C48Q55642833-7D34A57F-28DC-4293-901C-F1CF689BC0B1Q56526696-DDB4CFD9-8ED1-418E-AE88-F630A683057CQ56996146-3D847805-0632-4D59-A96D-742291DB3FAA
P2860
Coronary vein graft disease: pathogenesis and prevention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Coronary vein graft disease: pathogenesis and prevention.
@en
Coronary vein graft disease: pathogenesis and prevention.
@nl
type
label
Coronary vein graft disease: pathogenesis and prevention.
@en
Coronary vein graft disease: pathogenesis and prevention.
@nl
prefLabel
Coronary vein graft disease: pathogenesis and prevention.
@en
Coronary vein graft disease: pathogenesis and prevention.
@nl
P2860
P1476
Coronary vein graft disease: pathogenesis and prevention.
@en
P2093
Pirouz Parang
Rohit Arora
P2860
P304
P356
10.1016/S0828-282X(09)70486-6
P577
2009-02-01T00:00:00Z